Nephros, Inc. is a company that specializes in developing and marketing sophisticated water purification solutions across the United States, catering to both ...
Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer
Est. EPS $0.02 · Revenue $5.49M · 1 analysts
Est. EPS $0.02 · Revenue $5.41M · 1 analysts
Est. EPS $0.16 · Revenue $22.13M · 1 analysts
Est. EPS $0.04 · Revenue $5.97M · 1 analysts
| Metric | Latest | YoYYoY means Year-over-Year. It compares the latest annual value with the previous annual value to show long-term trend strength. | QoQQoQ means Quarter-over-Quarter. It compares the latest quarter with the immediately previous quarter to show short-term momentum changes. |
|---|---|---|---|
| RevenueThe total money that came through the front door from selling things, before paying a single bill. Think of it as the grand total of every credit card swipe from customers. (YoY compares this year to last year's performance, while QoQ compares the current three months to the previous three). | $18.8M | +32.7% | +15.4% |
| Net IncomeThe absolute bottom line. If the company paid every single supplier, employee, banker, and tax collector, this is the actual money left in their pocket at the end of the day. | $1.2M | +1513.5% | +755.0% |
| Gross MarginThe basic markup. If they sell a $100 pair of sneakers, this percentage tells you how much of that price tag is profit right after paying for the rubber and shoelaces, but before paying for things like store rent or TV commercials. | +61.1% | -0.8% | +16.8% |
| Operating MarginThe 'day job' efficiency score. Out of every dollar a customer spends, this shows how many cents the company keeps after making the product AND paying for all the everyday corporate overhead (like salaries, marketing, and keeping the lights on). | +6.1% | +14296.4% | +983.2% |
| Net MarginThe final take-home percentage. When you strip away every conceivable cost, tax, and interest payment, this is the exact number of cents the company truly gets to keep from every dollar in sales. | +6.4% | +1116.2% | +640.6% |
| Free Cash FlowThe holy grail of corporate cash. It's the spendable, physical money left over after the business pays for its daily operations AND buys the big, expensive upgrades (like new factories or servers) it needs to survive. This is the 'free' money they can use to pay dividends or buy back stock. | $1.6M | +400.7% | +140.8% |
| FCF MarginThe ultimate cash conversion rate. It shows how good the company is at turning regular sales directly into cold, hard, spendable cash. A high percentage means the business is an absolute cash-printing machine. | +8.8% | +326.7% | +135.3% |
| Debt / EquityThe financial risk gauge. It compares how much of the company's empire was built using borrowed money (loans) versus the owners' own money (shareholders). A high number means they are heavily leveraged and playing a riskier game; a low number means they are playing it safe. | 10.4% | -36.6% | -19.5% |
| Current RatioThe 12-month survival check. It simply compares the cash they have right now (plus things they can quickly turn into cash) against the immediate bills they absolutely must pay this year. A score above 1 means they have enough in the wallet to cover the upcoming bills without panicking. | 4.06x | -23.7% | -10.6% |
| Total AssetsThe absolute size of the company's empire. It bundles together absolutely everything of value they own—from the cash in the register and the inventory in the warehouse, to the software patents in the vault and the factories on the ground. | $13.6M | +21.7% | +14.3% |
| Metric | Annual (A vs E) | Annual Surprise | Quarter (A vs E) | Quarter Surprise |
|---|---|---|---|---|
| EPS Surprise | 0.11 vs 0.11 | 0.0% | 0.11 vs 0.00 | +3200.3% |
| Revenue Surprise | $18.8M vs $18.5M | +1.5% | $6.0M vs $5.0M | +20.5% |
| Date | Executive | Title | Security | Side | Shares | Price |
|---|---|---|---|---|---|---|
| Aug 18, 2026 | WEXFORD CAPITAL LP | 10 percent owner | Common Stock | A | 812 | $3.60 |
| Aug 18, 2026 | WEXFORD CAPITAL LP | 10 percent owner | Stock Option (Right to Buy) | D | 3,765 | $3.60 |
| Aug 12, 2026 | Amron Arthur H | director | Common Stock | A | 2,418 | — |
| May 11, 2026 | Amron Arthur H | director | Common Stock | A | 3,574 | — |
| Mar 23, 2026 | Banks Robert R. Jr. | officer: President and CEO | Stock Option (right to buy) | D | 120,000 | $1.44 |
Operator: Good afternoon, and welcome to the Nephros, Inc. Second Quarter 2026 Financial Results Conference Call. Please note this event is being recorded. I would now like to turn the conference over to Mr. Kirin Smith, Investor Relations. Please go ahead. Kirin Smith Thank you, operator, and good afternoon, everyone. This is Kirin Smith with PCG Advisory. Thank you all for participating in Nephros' Second Quarter 2026 Conference Call. Before we begin, I would like to caution that comments made during this conference call by management will contain forward-looking statements regarding the operations and future results of Nephros. I encourage you to review Nephros' filings with the Securities and Exchange Commission, including, without limitation, the company's Forms 10-K and 10-Q, which identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements. Factors that may affect the company's results include, but are not limited to, Nephros' ability to successfully timely and cost effectively market and sell its products and service offerings; the rate of adoption of its products and services by hospitals and other health care providers; the success of its commercialization efforts and the effect of existing and new regulatory requirements on Nephros' business and other economic and competitive factors. The content of this conference call contains time-sensitive information that is accurate only as of the date of the live call today, August 5, 2026. The company undertakes no obligation to revise or update any statements to reflect events or circumstances after the date of this conference call, except as required by law. I would now like to turn the call over to Nephros' President and Chief Executive Officer, Robert Banks. Robert, please go ahead. Robert Banks: Thank you, Kirin, and good afternoon, everyone. I'm very pleased to welcome you to the call. The second quarter of 2026 was an exceptional quarter for Nephros and represents another major step forward in the company's development. We generated $6 million in revenue, the highest quarterly revenue in our history and a 36% increase over the second quarter. Revenue also increased approximately 15% sequentially from our record first quarter. More important than the headline number is the quality and breadth of the growth. Our core programmatic product revenue increased by double digits year-over-year. This is the recurring foundation of our business. Customers install our products, incorporate them into their water management programs and continue purchasing replacement filters over time. Our service-only revenue nearly tripled as customers increasingly rely on Nephros for installation, replacement and ongoing support, not simply for the initial product purchase. Emergency response revenue also increased meaningfully during that -- during the quarter. That business can naturally fluctuate depending on outbreaks, …
| Name | Title | Compensation | Gender | Year Born | Status |
|---|---|---|---|---|---|
Robert Banks | President, Chief Executive Officer & Director | USD 627,125 | Male | 1975 | Active |
Judy F. Krandel | Chief Financial Officer | USD 204,764 | Female | 1965 | Active |
Greg Lucas | President of Aether Water Systems | — | Male | — | Active |
Michael Milman | Vice President of R&D | — | Male | — | Active |
Vashone R. Thomas | Vice President of Quality, Regulatory, & Human Resources | — | — | — | Active |
Brianne McGuire | Director of Brand, Marketing & Business Development | — | — | — | Active |
Judy Mazzini | Controller | — | Female | — | Active |
Nephros (NASDAQ: NEPH) reported record second-quarter revenue and sharply higher profitability, as growth in its recurring programmatic product business and service offerings helped drive results. Revenue for the three months ended June 30 rose 36% year over year to $6 million, compared with $4.4 million in the prior-year period. The company said revenue also increased about
Nephros, Inc. (NEPH) Q2 2026 Earnings Call Transcript
Record Second-Quarter Net Revenue Growth of 36% to $6 millionCore Programmatic Revenue Grew by 27% Year Over Year SOUTH ORANGE, NJ, August 6, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Nephros, Inc.
SOUTH ORANGE, N.J., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will file its second quarter financial results on Thursday, August 06, 2026 after market close and will host a conference call that same day at 4:30pm ET.
SOUTH ORANGE, NJ, July 20, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Nephros, Inc.
